Known targets — ChEMBL curated mechanism
ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR3 | O14843 | 2/20 | 0.88 |
| ▸ | LCK | P06239 | 1/20 | 0.88 |
| ▸ | FYN | P06241 | 1/20 | 0.88 |
| ▸ | LMNA | P02545 | 3/20 | 0.56 |
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
| ▸ | THPO | P40225 | 1/20 | 0.50 |
| ▸ | CA1 | P00915 | 3/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.46 |
| ▸ | BLM | P54132 | 1/20 | 0.46 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 2/20 | 0.44 |
| ▸ | CA9 | Q16790 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.39 |
| ▸ | MMP12 | P39900 | 1/20 | 0.39 |
| ▸ | CA4 | P22748 | 1/20 | 0.39 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.38 |
| ▸ | ACHE | P22303 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid SCHEMBL11400525 | 1.00 | FFAR3 (0.88) | FFAR3LCKFYNLMNATSHR | |
| Acetic Acid SCHEMBL462200 | 1.00 | FFAR3 (0.88) | FFAR3LCKFYNLMNATSHR | |
| Acetic Acid SCHEMBL8061222 | 1.00 | FFAR3 (0.88) | FFAR3LCKFYNLMNATSHR | |
| Acetic Acid SCHEMBL2848522 | 1.00 | FFAR3 (0.88) | FFAR3LCKFYNLMNATSHR | |
| Acetic Acid SCHEMBL11246672 | 1.00 | FFAR3 (0.88) | FFAR3LCKFYNLMNATSHR | |
| Acetic Acid SCHEMBL21197465 | 1.00 | FFAR3 (0.88) | FFAR3LCKFYNLMNATSHR | |
| Acetic Acid SCHEMBL2916665 | 1.00 | — | — | |
| Acetic Acid SCHEMBL20553940 | 1.00 | FFAR3 (0.88) | FFAR3LCKFYNLMNATSHR | |
| Acetic Acid SCHEMBL21596426 | 1.00 | FFAR3 (0.88) | FFAR3LCKFYNLMNATSHR | |
| Acetic Acid SCHEMBL11962949 | 1.00 | FFAR3 (0.88) | FFAR3LCKFYNLMNATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240182734-A1 | Ink Jet Ink Composition And Recording Method | SEIKO EPSON CORPORATION (JP) | 2024-06-06 | — | — | US | disclosed |
| CN-112697892-B | Method for quantitatively detecting cyclic alkyl sulfonate component and residual oil sulfonate component in petroleum production liquid | 中国石油天然气股份有限公司 | 2023-04-25 | — | — | CN | disclosed |
| CN-112334551-B | Acylphosphine oxide initiators | 爱克发有限公司 | 2022-11-08 | — | — | CN | disclosed |
| WO-2022224945-A1 | COLORED DISPERSION | 日本化薬株式会社 | 2022-10-27 | — | — | WO | disclosed |
| CN-109071979-B | Acylphosphine oxide photoinitiators | 爱克发有限公司 | 2022-07-01 | — | — | CN | disclosed |
| US-20210283938-A1 | A LITHOGRAPHIC PRINTING PLATE PRECURSOR | AGFA NV (BE) | 2021-09-16 | — | — | US | disclosed |
| US-11053404-B2 | Acylphosphine oxide photoinitiators | AGFA NV (BE) | 2021-07-06 | — | — | US | disclosed |
| EP-3810710-A1 | ACYLPHOSPHINEOXIDE INITIATORS | AGFA NV (BE) | 2021-04-28 | — | — | EP | disclosed |
| CN-112334551-A | Acylphosphine oxide initiators | 爱克发有限公司 | 2021-02-05 | — | — | CN | disclosed |
| WO-2019243039-A1 | ACYLPHOSPHINEOXIDE INITIATORS | AGFA NV (BE) | 2019-12-26 | — | — | WO | disclosed |
| CN-110546567-A | Lithographic printing plate precursor | AGFA NV | 2019-12-06 | — | — | CN | disclosed |
| US-20190144695-A1 | ACYLPHOSPHINE OXIDE PHOTOINITIATORS | AGFA NV (BE) | 2019-05-16 | — | — | US | disclosed |
| CN-109071979-A | ACYLPHOSPHINE OXIDE PHOTOINITIATORS | 爱克发有限公司 | 2018-12-21 | — | — | CN | disclosed |
| WO-2018192932-A1 | A LITHOGRAPHIC PRINTING PLATE PRECURSOR | AGFA NV (BE) | 2018-10-25 | — | — | WO | disclosed |
| EP-3392709-A1 | A LITHOGRAPHIC PRINTING PLATE PRECURSOR | AGFA NV (BE) | 2018-10-24 | — | — | EP | disclosed |
| CN-103755591-A | Preparation method of auramine O standard detection sample | SHENYANG PRODUCT QUALITY SUPERVISION AND INSPECTION INST | 2014-04-30 | — | — | CN | disclosed |
| CN-103760002-A | Preparation method for detecting basic orange II standard sample | SHENYANG PRODUCT QUALITY SUPERVISION AND INSPECTION INST | 2014-04-30 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210283938-A1 | A LITHOGRAPHIC PRINTING PLATE PRECURSOR | LOXL1, LOXL2, LOXL3 | FFAR3 3914/4885LCK 4136/4885FYN 4370/4885 |
| US-20190144695-A1 | ACYLPHOSPHINE OXIDE PHOTOINITIATORS | AGPAT5, AGPAT2, TST | FFAR3 4399/4885LCK 1835/4885FYN 2636/4885 |
| US-11053404-B2 | Acylphosphine oxide photoinitiators | AGPAT5, AGPAT2, TST | FFAR3 4399/4885LCK 1835/4885FYN 2636/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.